SoftWave officially has been granted 4 new patents as of July 19, 200. They include e U.S. Patient No. 11,389,373 B2 for Acoustic shock wave therapeutic methods to prevent or treat opioid addiction, U.S. Patient No. 11,389,370 B2 for Treatments for blood sugar levels and muscle tissue optimization, U.S. Patient No. 11,389,371 B2 and U.S. Patient No. 11,389,372 B2 for Acoustic shock wave Therapeutic methods.
For a glance at all 4 at one time, click here.
Full individual links: